This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Visit Pfizer Medical site



Sign In or RegisterLog Out
Pfizer MedicinesTherapy AreasExplore ContentEventsVideosMaterialsFeatured ArticlesLet’s ConnectSupplyOff-contract claimsAlliance Healthcare

Example content



AMSAMSAn introduction to antimicrobial stewardshipStewardshipSurveillanceRace against resistanceABSABSABS in practice Educational ResourcesAFSAFSShape the futureAFS in practiceImplementing an AFS programmeDiagnosticsGuidelinesCase studiesAll case studiesDisease AwarenessDisease AwarenessAspergillosisOur CommitmentOur CommitmentOur commitment to anti-infectivesHeritageSustainability
Our work in the community
Support & ResourcesSupport & ResourcesVideosMaterialsOnline LearningOnline LearningHomeINSPIRE To: Change the CourseINSPIRE To: Change the Course Season 2The global threat of carbapenemase-producing enterobacterales (CPE)CPE Epidemiology CPE Factsheet London AMS SeriesNorth West England AMS SeriesInfectious Thinking Podcasts
AMS in PracticeIntroduction to Antimicrobial Stewardship Programmes (ASPs)

Antimicrobial stewardship (AMS) is a coherent set of actions that promote the optimal use of antimicrobials in a way that ensures sustainable access to effective therapy for all in need.1 ASPs aim to improve patient outcomes and safety and address inappropriate use of antimicrobials. Core elements identified in successful ASPs include leadership commitment, prescriber accountability, drug expertise, and education of clinicians and patients, among others.2 The general framework of an ASP has ideally three components:1

  • There are system prerequisites that must be met before implementation (e.g. presence of guidelines, AMS team, adequate diagnostic, human and IT resources)
  • What the AMS team wants to improve must be clearly defined (recommendations on appropriate use at the patient level, i.e. duration of treatment compliant with guidelines)
  • How the AMS team will achieve these goals must be planned, i.e. the improvement strategies that will be chosen and tailored based on the identified determinants and problems and performed by the team at the professional or institutional level
What is antimicrobial stewardship and why is it important?How are the antimicrobial stewardship programs implemented and what are the main goals?How is the clinical and economic impact of an antimicrobial stewardship program measured?

How can Pfizer support?

Delivering an Antimicrobial Stewardship Programme is a multi staged process requiring a coordinated response from a range of healthcare professionals. To support with this, Pfizer have created an Antimicrobial Stewardship Toolkit for healthcare professionals looking to enhance their antimicrobial stewardship capabilities. The AMS toolkit contains a variety of resources designed to offer advice, suggestions and tips for implementing and maintaining AMS programmes within the secondary healthcare setting.

To access these resources please visit our Educational Resources Page

If you would like to speak with one of the Pfizer team about how we can provide additional support, please use the 'Virtual Assistant' button found on our website and we'll get back to you

AMS Lead Resource Pack - 'At a Glance'

Leading an AMS programme is a multi-faceted process requiring a coordinated response that engages colleagues and supports their active involvement. This pack is designed to help you and your AMS Champions deliver excellent and consistent patient care through collaboration between all members of the team.

AMS Champion Resource Pack - 'At a Glance'

As an AMS Champion you play a key role in engaging with colleagues and supporting their active involvement with Antimicrobial Stewardship. The items within this pack are designed to help AMS Champions develop excellent and consistent patient care through collaboration with all members of the hospital team.



Mendelson M, et al. How to start an antimicrobial stewardship programme in a hospital. Clin Microbiol & Infect. 2019 [Article in press].Nathwani D, et al. Value of hospital antimicrobial stewardship programs [ASPs]: a systematic review. Antimicrob Resist Infect Control. 2019;8:35.
PP-CRB-GBR-2095. September 2023
Educational Resources

We have a variety of educational resources aimed at supporting Healthcare Professsionals looking to enhance their knowledge of AMR and Stewardship.

Access resourcesLoading

Adverse events should be reported. Reporting forms and information can be found at or search 

for MHRA Yellow Card in Google Play or Apple App Store


Adverse events should also be reported to Pfizer Medical Information on 01304 616161

PfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign In or RegisterAccountSign Out

This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit


This website is brought to you by Pfizer Limited, a company registered in England 

and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ


Copyright © 2024 Pfizer Limited. All rights reserved.


VAT registration number GB201048427

PP-UNP-GBR-7866. January 2024
For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-UNP-GBR-7812. January 2024

You are now leaving PfizerPro​​​​​

​​​​​​​You are now leaving Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site.​​​​​​​​​​​​​​

​​​​​​​PP-PFE-GBR-3858. November 2021​​​​​​​
You are now leaving PfizerPro
​​​​​​​You are now leaving Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer medicines or 
business which it has provided or reviewed.

PP-PFE-GBR-3859. November 2021